Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Часто задаваемые вопросы
В каком секторе работает Akoya BioSciences, Inc. Common Stock (AKYA)?
Akoya BioSciences, Inc. Common Stock относится к сектору Здравоохранение.
Какова текущая цена акций Akoya BioSciences, Inc. Common Stock (AKYA)?
По последним данным, цена акций Akoya BioSciences, Inc. Common Stock составляет 1,29 $, предыдущее закрытие — 1,29 $.
Выплачивает ли Akoya BioSciences, Inc. Common Stock (AKYA) дивиденды?
Нет, Akoya BioSciences, Inc. Common Stock не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Akoya BioSciences, Inc. Common Stock (AKYA)?
У компании Akoya BioSciences, Inc. Common Stock бета 1.352, что указывает на повышенную волатильность по сравнению с рынком.